Three bodies govern what you can make and claim in pet products. Understanding which applies to your product type is the first gate before you brief a single manufacturer.

FDA and the Food Safety Modernization Act (FSMA). The FDA regulates pet food under the Federal Food, Drug, and Cosmetic Act. FSMA's Preventive Controls for Animal Food rule (21 CFR Part 507) sets food safety plan requirements for pet food manufacturers — hazard analysis, preventive controls, recall procedures, and supplier verification. Any facility co-packing pet food for US sale should be FSMA Part 507-compliant. Confirm FDA facility registration and ask for the food safety plan status when vetting a co-packer.

AAFCO: nutritional standards, not a certification body. AAFCO (Association of American Feed Control Officials) is a non-governmental body that publishes the Official Publication — the nutrient profiles and labeling guidelines that most US states adopt into law through their feed control regulations. AAFCO does not certify products or manufacturers. What AAFCO gives you is the standard your formulation must meet to carry a "complete and balanced" claim. Your contract manufacturer's nutritionist runs the formulation against AAFCO Dog Food or Cat Food nutrient profiles and generates the substantiation documentation. If selling treats or supplements (not complete diets), AAFCO complete-diet compliance is not required — but ingredients must still be approved or GRAS for animal feed use.

NASC: the quality standard for pet supplements. The National Animal Supplement Council Quality Seal is not an FDA program. It's a voluntary industry audit — facilities apply, pass a third-party inspection against NASC quality guidelines, and earn the right to display the seal on their products. NASC also requires members to maintain adverse event reporting. In specialty pet retail and serious DTC channels, the NASC seal has become a de facto qualification floor. Brands without it face harder shelf conversations with pet-specialty buyers.

State feed control authorities. Feed regulations are administered state by state through feed control officials who are members of AAFCO. Some states require product registration before sale — the feed registration requirements for pet food vary by state. If you are selling nationally and your product has an AAFCO complete-diet statement, budget 4–8 weeks for state feed registration in your key distribution states. Your co-packer should have this process documented.

See also: AAFCO standards explained and pet care industry sourcing overview.

Pet products span a wide range of manufacturing complexity. Here are the typical MOQ ranges and format considerations across major pet product categories. All figures are typical industry ranges — actual quotes depend on ingredient deck, run complexity, and co-packer scale.

Soft chews (the dominant pet supplement format). Soft chews are the workhorse of the pet supplement category — palatability is high, dosing is easy for owners, and they photograph well for DTC marketing. MOQ: 1,000–3,000 units for stock-formula soft chews. Custom soft chew formulations typically require 3,000–5,000 units minimum. The chew base (chicken liver, duck, bacon flavor) is a palatability variable — confirm the flavoring system source and whether it's a real protein base vs synthetic flavor. Lead time: 10–16 weeks for custom, 8–10 weeks for stock formula with your label.

Dry treats (baked, freeze-dried, dehydrated). Baked dog biscuits: MOQ 500–2,000 units depending on recipe complexity and bag format. Freeze-dried treats carry higher per-unit cost due to equipment intensity — MOQs run 1,000–5,000 units, and per-unit cost is typically 2–4x equivalent baked treats. Dehydrated single-ingredient treats (chicken strips, salmon skin) have lower formulation complexity but often shorter shelf life — confirm water activity testing is part of the QC protocol.

Pet food (kibble, wet food, raw). Kibble co-packing has the highest minimum run volume in the category — typically 5,000–25,000 lbs or more. This is not a starting format for most first-run private label brands. Wet food (pate, shredded) runs 5,000–15,000 cans/pouches minimum. Raw frozen and freeze-dried raw are smaller-run-friendly but require cold chain logistics from manufacturer to consumer. These categories are best for brands with established distribution and a clear path to volume.

Pet supplements (capsules, powders, liquids). Capsules and powders for pets often run on the same equipment as human supplements — MOQs are comparable: 500–1,500 units. Liquids (joint oils, fish oil blends) run 500–2,000 units. The key difference from human supplements is that palatability must be considered — most pets won't take an unflavored capsule willingly. Powder supplements that mix into food are the most practical format for compliance-sensitive owners.

Toys and accessories. Non-consumables (toys, collars, leashes, beds) have different sourcing dynamics — these are primarily manufactured in China and assembled or finished domestically for higher-margin positioning. MOQs depend on material and construction: injection-molded rubber toys run 500–2,000 units; fabric-based toys and accessories run 200–500 units from capable OEMs. CPSC safety requirements apply to some pet toys — confirm the facility's knowledge of applicable standards for your product category.

Ingredient quality is the primary differentiator in premium pet product positioning — and it's also where the most deceptive sourcing practices happen. Here is how to evaluate what you're actually buying.

Named protein sources vs generic meat designations. "Chicken" means muscle meat from chickens. "Chicken meal" means rendered, concentrated chicken protein — not inherently inferior, and often higher in protein concentration than fresh chicken by weight. "Meat by-products" and "animal digest" are less transparent — these are rendered from unspecified animal sources. "Poultry" is less specific than "chicken." For premium positioning, named protein sources are the standard — both because they support cleaner label claims and because customers increasingly demand them.

Ingredient order as a proxy for inclusion rate. Ingredients are listed by weight before processing. A treat with "chicken" as the first ingredient but corn gluten meal as the second and third may have a lower real protein content than it appears — moisture is included in the fresh-chicken weight, which evaporates during processing. Ask your manufacturer for the dry matter analysis, not just the ingredient list order.

Supplement ingredient sourcing transparency. For joint supplements: glucosamine sulfate and chondroitin sulfate should come from a named source (shellfish-derived glucosamine is standard; bovine trachea-derived chondroitin is common). Ask for the supplier and country of origin. Fish oil: confirm EPA/DHA concentration, species source, and whether it's been third-party tested for heavy metals and oxidation (TOTOX value). Probiotics: confirm CFU count at end of shelf life, not at manufacture — probiotic viability degrades with time.

Filler identification in treats and chews. Fillers in pet products serve functional purposes (binding, palatability, shelf life) but dilute nutritional value. Maltodextrin, glycerin, and various starches are common. Glycerin is often the binding agent in soft chews — it's not harmful, but high glycerin content means lower active-ingredient concentration per chew. Know the inclusion rate of your actives per chew before you brief the label copy.

Testing for what the label claims. Heavy metals testing is critical for fish-derived ingredients and liver-based products — organ meats bioaccumulate lead and cadmium. Confirm your co-packer tests finished products for heavy metals, not just raw materials. For supplement actives: potency testing on the finished chew or powder — not just the raw ingredient certificate — is the standard expected by serious pet specialty retailers.

Lead times in pet products are broadly comparable to human consumer goods in the same format, with some category-specific differences. Here is what to expect — and where founders get surprised.

Soft chews (stock formula). 8–12 weeks from signed PO to finished goods. The largest variable is packaging: custom-printed stand-up pouches with resealable zippers require 4–6 weeks of print and production time. If you're using stock packaging with a label, you save 3–4 weeks. First runs often run 10–14 weeks due to label review and approvals that weren't anticipated.

Soft chews (custom formula). 16–24 weeks. Add 4–8 weeks for formula development, palatability testing, and approval. Stability data for soft chews — confirming active-ingredient retention and microbial safety over the stated shelf life — adds another 3–6 weeks if the manufacturer doesn't already have it for your base formula.

Dry treats. 6–10 weeks for baked treats on existing recipes. Custom recipe development adds 8–12 weeks. Freeze-dried single-ingredient treats on existing protocols: 8–12 weeks. New protein sources or novel formats: 12–18 weeks including validation.

Pet food (kibble). 18–30 weeks for a custom formulation with AAFCO substantiation. The formulation review and state feed registration steps drive the long tail — plan for 20+ weeks minimum on a first-run product. Stock formula kibble with your label is faster: 12–16 weeks.

Supplements (capsules, powders). Match human supplement lead times: 8–12 weeks stock, 14–20 weeks custom. Liquids with specific flavor masking for palatability add 4–6 weeks for development and taste testing.

The lead time variable nobody quotes: regulatory review. If your product requires state feed registration, add 4–8 weeks in regulated states. If you're making a new drug-adjacent claim that triggers FDA inquiry, plan for an indefinite delay while you resolve the labeling issue. The fastest way to compress lead time is to brief the manufacturer with a complete regulatory brief — species, format, benefit claim, and any prior label copy — before requesting a quote. Facilities that receive complete briefs move faster than those that spend the first two weeks asking basic questions back.

See also: lead time glossary definition and private label services.

Pet supplements occupy a regulatory gray zone that is more permissive than pet food in some ways and more scrutinized in others. Here is the operative framework.

Pet supplements are not pet food. They are not regulated as drugs (unless they make a drug claim). They sit in a category that FDA acknowledges but has not fully defined by rule. The practical governance comes from NASC guidelines, state feed control officials, and FTC truth-in-advertising standards. Most serious manufacturers operating in this space follow NASC guidelines as the industry standard.

What claims you can make. Structure-function type claims are standard in pet supplements: "supports hip and joint health," "supports healthy skin and coat," "supports a calm temperament." Disease claims are prohibited: "treats arthritis," "cures anxiety." The line is similar to human supplement DSHEA rules — describe the benefit in support language, not treatment language. The FTC enforces advertising claims; FDA enforces label claims. Both are active in this space.

The NASC adverse event reporting requirement. NASC members are required to maintain and submit adverse event reports. If a pet owner reports a problem with your product through the manufacturer, it should flow into the NASC adverse event reporting system. This matters for you as the brand owner — confirm your manufacturing agreement specifies how adverse events are communicated to you and how quickly.

Drug-adjacent actives that create risk. Some ingredients common in pet supplements edge toward drug territory when combined with specific claims. Melatonin with a "sleep" claim has been questioned. Valerian or CBD products involve additional complexity. If your formula includes any novel or FDA-flagged ingredient, get explicit written guidance from a regulatory attorney before finalizing the label. Your manufacturer's marketing team is not a substitute for regulatory counsel.

The interaction with Amazon, Chewy, and pet specialty retail. Major pet specialty retailers (Chewy, PetSmart, Petco, independent pet specialty chains) and Amazon's pet category have their own supplier qualification requirements that layer on top of FDA/NASC minimums. Chewy's supplier qualification requires manufacturer documentation, COAs, and in some cases third-party testing results. Know the buyer requirements of your target channel before finalizing your manufacturing agreement — it's easier to build in compliance requirements upfront than to retrofit them after your first PO.

See also: third-party testing requirements and contract manufacturing services.

The same three-tier sourcing model applies in pet products as in human supplements, with some pet-specific nuances worth understanding.

White label (stock formula, your label). The fastest path to market. The facility has a stock chicken soft chew joint formula — you put your brand on it. No formula exclusivity. Your competitors can source the same base. Best for: testing a new species or benefit claim, filling out a product line without formula investment, launching quickly to validate demand before committing to development. MOQ: 1,000–2,000 units. Lead time: 8–12 weeks. Per-unit cost: lowest among the three models.

Private label (stock base, modifications). You start with the facility's stock formula and request modifications — a different protein source for the palatability base, an added ingredient, a different chew size or texture. This creates moderate differentiation and may allow limited exclusivity on the specific modification. MOQ: 2,000–5,000 units. Lead time: 12–18 weeks. Cost: 15–30 percent above white label.

Custom formulation. Your formula developed from scratch — specific actives, specific dosing matrix, specific flavoring system, your intellectual property. Requires full stability validation and palatability testing. MOQ: 5,000–10,000 units. Lead time: 16–26 weeks. Cost: 30–60 percent above white label at comparable volume, lower at high volume. Best for: hero SKU, clinical-dosing differentiation, branded-ingredient strategy (licensed actives like Boswellia extract from a specific supplier).

The path most sustainable brands follow: white label to validate the category, private label modification to start differentiation, custom formulation once volume justifies the investment. Each step funds the next. See also: private label vs white label breakdown and MOQ explained.